KYORIN Holdings, Inc. (4569.T)
JPY 1440.0
(-0.89%)
JPY 1440.0
(-0.89%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 119.53 Billion JPY | 5.53% |
| 2022 | 113.27 Billion JPY | 7.33% |
| 2021 | 105.53 Billion JPY | 2.56% |
| 2020 | 102.9 Billion JPY | -6.44% |
| 2019 | 109.98 Billion JPY | -3.2% |
| 2018 | 113.62 Billion JPY | 2.69% |
| 2017 | 110.64 Billion JPY | -4.1% |
| 2016 | 115.37 Billion JPY | -3.44% |
| 2015 | 119.48 Billion JPY | 5.62% |
| 2014 | 113.12 Billion JPY | 1.54% |
| 2013 | 111.4 Billion JPY | 4.08% |
| 2012 | 107.03 Billion JPY | 3.68% |
| 2011 | 103.23 Billion JPY | -0.8% |
| 2010 | 104.06 Billion JPY | 4.32% |
| 2009 | 99.76 Billion JPY | 9.76% |
| 2008 | 90.88 Billion JPY | 12.11% |
| 2007 | 81.07 Billion JPY | 5.16% |
| 2006 | 77.09 Billion JPY | 4.1% |
| 2005 | 74.05 Billion JPY | 11.7% |
| 2004 | 66.29 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 28.41 Billion JPY | -11.92% |
| 2023 Q1 | 27.85 Billion JPY | -14.46% |
| 2023 Q4 | 32.26 Billion JPY | -0.2% |
| 2023 FY | 119.53 Billion JPY | 5.53% |
| 2023 Q3 | 32.33 Billion JPY | 19.37% |
| 2023 Q2 | 27.08 Billion JPY | -2.77% |
| 2022 Q3 | 31.61 Billion JPY | 29.17% |
| 2022 Q4 | 32.56 Billion JPY | 3.0% |
| 2022 Q1 | 24.61 Billion JPY | -11.5% |
| 2022 Q2 | 24.47 Billion JPY | -0.59% |
| 2022 FY | 113.27 Billion JPY | 7.33% |
| 2021 Q2 | 24.4 Billion JPY | -1.17% |
| 2021 FY | 105.53 Billion JPY | 2.56% |
| 2021 Q3 | 28.61 Billion JPY | 17.24% |
| 2021 Q4 | 27.81 Billion JPY | -2.79% |
| 2021 Q1 | 24.69 Billion JPY | -11.64% |
| 2020 Q1 | 24.68 Billion JPY | -21.29% |
| 2020 Q4 | 27.94 Billion JPY | 2.68% |
| 2020 Q2 | 23.04 Billion JPY | -6.65% |
| 2020 Q3 | 27.22 Billion JPY | 18.11% |
| 2020 FY | 102.9 Billion JPY | -6.44% |
| 2019 Q4 | 31.36 Billion JPY | 3.48% |
| 2019 Q1 | 25.74 Billion JPY | -18.52% |
| 2019 Q2 | 22.55 Billion JPY | -12.42% |
| 2019 Q3 | 30.31 Billion JPY | 34.43% |
| 2019 FY | 109.98 Billion JPY | -3.2% |
| 2018 Q1 | 25.13 Billion JPY | -9.33% |
| 2018 Q4 | 31.6 Billion JPY | -0.17% |
| 2018 Q2 | 25.22 Billion JPY | 0.39% |
| 2018 Q3 | 31.65 Billion JPY | 25.48% |
| 2018 FY | 113.62 Billion JPY | 2.69% |
| 2017 Q1 | 26.45 Billion JPY | -7.29% |
| 2017 Q4 | 27.71 Billion JPY | -13.83% |
| 2017 Q3 | 32.16 Billion JPY | 32.37% |
| 2017 Q2 | 24.3 Billion JPY | -8.16% |
| 2017 FY | 110.64 Billion JPY | -4.1% |
| 2016 Q1 | 27.7 Billion JPY | -7.69% |
| 2016 FY | 115.37 Billion JPY | -3.44% |
| 2016 Q3 | 32.2 Billion JPY | 19.64% |
| 2016 Q4 | 28.53 Billion JPY | -11.4% |
| 2016 Q2 | 26.92 Billion JPY | -2.84% |
| 2015 FY | 119.48 Billion JPY | 5.62% |
| 2015 Q3 | 37.08 Billion JPY | 43.63% |
| 2015 Q2 | 25.81 Billion JPY | -2.82% |
| 2015 Q1 | 26.56 Billion JPY | -10.0% |
| 2015 Q4 | 30.01 Billion JPY | -19.06% |
| 2014 FY | 113.12 Billion JPY | 1.54% |
| 2014 Q2 | 24.71 Billion JPY | -6.37% |
| 2014 Q3 | 32.49 Billion JPY | 31.46% |
| 2014 Q4 | 29.51 Billion JPY | -9.14% |
| 2014 Q1 | 26.39 Billion JPY | -5.62% |
| 2013 Q3 | 32.57 Billion JPY | 32.37% |
| 2013 Q4 | 27.97 Billion JPY | -14.15% |
| 2013 Q2 | 24.61 Billion JPY | -6.2% |
| 2013 Q1 | 26.23 Billion JPY | -5.62% |
| 2013 FY | 111.4 Billion JPY | 4.08% |
| 2012 Q1 | 25.42 Billion JPY | -1.54% |
| 2012 FY | 107.03 Billion JPY | 3.68% |
| 2012 Q4 | 27.8 Billion JPY | -11.1% |
| 2012 Q3 | 31.27 Billion JPY | 38.8% |
| 2012 Q2 | 22.53 Billion JPY | -11.37% |
| 2011 FY | 103.23 Billion JPY | -0.8% |
| 2011 Q2 | 21.57 Billion JPY | -13.02% |
| 2011 Q3 | 31.02 Billion JPY | 43.79% |
| 2011 Q4 | 25.81 Billion JPY | -16.78% |
| 2011 Q1 | 24.8 Billion JPY | -12.17% |
| 2010 Q2 | 22.05 Billion JPY | -10.56% |
| 2010 Q1 | 24.65 Billion JPY | -2.1% |
| 2010 FY | 104.06 Billion JPY | 4.32% |
| 2010 Q4 | 28.24 Billion JPY | -2.97% |
| 2010 Q3 | 29.11 Billion JPY | 32.02% |
| 2009 FY | 99.76 Billion JPY | 9.76% |
| 2009 Q2 | 22.42 Billion JPY | -3.71% |
| 2009 Q3 | 28.86 Billion JPY | 28.71% |
| 2009 Q4 | 25.18 Billion JPY | -12.75% |
| 2009 Q1 | 23.28 Billion JPY | -5.05% |
| 2008 FY | 90.88 Billion JPY | 12.11% |
| 2008 Q3 | 26.1 Billion JPY | 33.82% |
| 2008 Q4 | 24.52 Billion JPY | -6.02% |
| 2008 Q2 | 19.5 Billion JPY | 0.0% |
| 2007 FY | 81.07 Billion JPY | 5.16% |
| 2006 FY | 77.09 Billion JPY | 4.1% |
| 2005 FY | 74.05 Billion JPY | 11.7% |
| 2004 FY | 66.29 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -92.338% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 97.197% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 62.0% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 72.526% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -1444.655% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 19.374% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -65.915% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 83.885% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -863.502% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 15.648% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -16.18% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -115.738% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -288.747% |
| Tsumura & Co. | 150.84 Billion JPY | 20.758% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -58.155% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -118.771% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 47.559% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -192.333% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -57.85% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -2271.667% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -154.893% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -2038.43% |
| MedRx Co., Ltd | 26 Million JPY | -459638.462% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -987.67% |
| Solasia Pharma K.K. | 617 Million JPY | -19273.096% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -90.207% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 32.415% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -195494.973% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 91.906% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -440.034% |